Roche to Acquire Carmot Therapeutics for US$3.1 B

By Ayush Saxena

Pharma Deals Review: Vol 2023 Issue 12 (Table of Contents)

Published: 14 Dec-2023

DOI: 10.3833/pdr.v2023.i12.2845     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

In order to expand its metabolic diseases portfolio, Roche has agreed to acquire Carmot Therapeutics for US$3...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details